Switch to:

Key Ratios

New Key Statistics Module, Z-Score and F-Score
Market Cap $M26.2Revenue (TTM) $M13.1Net Margin (%)-71.4Altman Z-Score-9.1
Enterprise Value $M-7.6EPS (TTM) $-0.9Operating Margin %-73.0Piotroski F-Score3
P/E(ttm)--Beneish M-Score-3.4Pre-tax Margin (%)-71.4Higher ROA y-yN
Price/Book0.610-y EBITDA Growth Rate %-21.8Quick Ratio5.3Cash flow > EarningsY
Price/Sales1.95-y EBITDA Growth Rate %-8.9Current Ratio5.3Lower Leverage y-yY
Price/Free Cash Flow--y-y EBITDA Growth Rate %--ROA % (ttm)-18.9Higher Current Ratio y-yN
Dividend Yield %--PEG--ROE % (ttm)-21.2Less Shares Outstanding y-yN
Payout Ratio %--Shares Outstanding M11.1ROIC % (ttm)-102.5Gross Margin Increase y-yY

Gurus Latest Trades with VICL

Number of guru portfolios checked: 68.
Ticker Guru Date Action
Impact Price Range
(Average)*
Current Price Change from Average Comment Current Shares

VICL is held by these investors:



VICL: Insider Buys/Sells

Click Here for All Insider Trades.
InsiderPosition Date Trades Shares Trade Price ($) Change (%) Details
Ramos Anthony AlanVP, Chief Accounting Officer 2017-03-27Sell4,250$2.178.76view
SMITH LAWRENCE RUSSELLVP, Vaccine Research 2017-03-15Sell875$2.312.16view
SMITH LAWRENCE RUSSELLVP, Vaccine Research 2017-02-10Sell4,500$2.264.42view
SAMANT VIJAY BPresident & CEO 2017-02-01Sell3,750$2.169.26view
SMITH LAWRENCE RUSSELLVP, Vaccine Research 2017-01-11Sell54$2.48-4.84view
SAMANT VIJAY BPresident & CEO 2017-01-10Sell5,763$2.45-3.67view
MERTON ROBERT CDirector 2016-12-22Sell4,000$2.245.36view
MERTON ROBERT CDirector 2016-12-20Sell4,327$2.216.79view
SAMANT VIJAY BPresident & CEO 2016-12-13Sell15,699$2.39-1.26view
DOUGLAS R GORDONDirector 2016-12-12Sell10,078$2.39-1.26view

Press Releases about VICL :

Quarterly/Annual Reports about VICL:

News about VICL:

Articles On GuruFocus.com
Vical to Present VL-2397 Data at the June ASM Microbe 2017 Meeting May 23 2017 
Vical Reports First Quarter 2017 Financial Results May 15 2017 
Vical Announces News Release and Conference Call Schedule for First Quarter 2017 Financial Results May 08 2017 
Vical Highlights Successful Outcome of Phase 1 Trial of VL-2397 Novel Antifungal During its Research May 02 2017 
Vical to Host Virtual Research & Development Day on May 2, 2017 Apr 24 2017 
Vical Completes Target Enrollment in Its Phase 2 Therapeutic HSV-2 Vaccine Trial Apr 19 2017 
Vical to Provide Company Update at the 29th Annual ROTH Conference Mar 10 2017 
Vical Reports Fourth Quarter 2016 Financial Results Mar 09 2017 
Vical to Provide Company Update at BIO Asia International Conference Mar 09 2017 
CEOs Sell Vical, PhotoMedex, E.W. Scripps, Smart & Final Stores Jan 18 2016 

More From Other Websites
Vical to Present VL-2397 Data at the June ASM Microbe 2017 Meeting May 23 2017
Edited Transcript of VICL earnings conference call or presentation 15-May-17 4:00pm GMT May 21 2017
Investor Network: Vical Incorporated to Host Earnings Call May 15 2017
Vical reports 1Q loss May 15 2017
Vical Reports First Quarter 2017 Financial Results May 15 2017
Investor Network Invites You to the Vical First Quarter 2017 Earnings Webcast Live on Monday, May... May 12 2017
Vical Announces News Release and Conference Call Schedule for First Quarter 2017 Financial Results May 08 2017
Vical Highlights Successful Outcome of Phase 1 Trial of VL-2397 Novel Antifungal During its Research... May 02 2017
Vical to Host Virtual Research & Development Day on May 2, 2017 Apr 24 2017
Vical Completes Target Enrollment in Its Phase 2 Therapeutic HSV-2 Vaccine Trial Apr 19 2017
ETFs with exposure to Vical, Inc. : April 5, 2017 Apr 05 2017
Vical, Inc. :VICL-US: Earnings Analysis: Q4, 2016 By the Numbers : March 15, 2017 Mar 15 2017
Vical to Provide Company Update at the 29th Annual ROTH Conference Mar 10 2017
Vical to Provide Company Update at BIO Asia International Conference Mar 09 2017
Vical Reports Fourth Quarter 2016 Financial Results Mar 09 2017
Investor Network Invites You to the Vical Fourth Quarter 2016 Earnings Webcast Live on Thursday,... Mar 08 2017
Vical Announces News Release and Conference Call Schedule for Fourth Quarter 2016 Financial Results Mar 02 2017

Add Notes, Comments

If you want to ask a question or report a bug, please create a support ticket.
Get WordPress Plugins for easy affiliate links on Stock Tickers and Guru Names | Earn affiliate commissions by embedding GuruFocus Charts
GuruFocus Affiliate Program: Earn up to $400 per referral. ( Learn More)